The Ubiquitin Proteasome System as a Potential Target for the Treatment of Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|18|3305-3314

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.18, 2013-06, pp. : 3305-3314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 1070-1074

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-01 ,pp. : 4053-4093

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 6, 2004-01 ,pp. : 515-533

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies

By  

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 338-346

Bentham Science Publishers

Access to resources Recommend Favorite